|
|
Volumn 19, Issue 12, 2001, Pages 496-499
|
|
Drug discovery of the future: The implications of the human genome project
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG DOSAGE;
DRUG PRODUCTS PLANTS;
THROUGHPUT;
HUMAN GENOME PROJECTS;
BIOTECHNOLOGY;
BETA SECRETASE;
CARBOHYDRATE BINDING PROTEIN;
CELL NUCLEUS RECEPTOR;
DNA;
DOPAMINE RECEPTOR;
MEMBRANE RECEPTOR;
MESSENGER RNA;
PHOSPHOTRANSFERASE;
PROTEINASE;
SOMATOMEDIN RECEPTOR;
BIOTECHNOLOGY;
DRUG DEVELOPMENT;
GENOME;
ACETYLATION;
ALTERNATIVE RNA SPLICING;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG TARGETING;
GENOTYPE;
HUMAN;
MEDICAL GENETICS;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN GLYCOSYLATION;
PROTEIN PHOSPHORYLATION;
PROTEIN PROTEIN INTERACTION;
PROTEIN STRUCTURE;
REVIEW;
RNA EDITING;
RNA TRANSCRIPTION;
SINGLE NUCLEOTIDE POLYMORPHISM;
TRANSCRIPTION REGULATION;
VALIDATION PROCESS;
COMPUTATIONAL BIOLOGY;
DRUG DESIGN;
DRUG INDUSTRY;
GENOME, HUMAN;
HUMANS;
MODELS, BIOLOGICAL;
|
|
EID: 0035575637
PISSN: 01677799
EISSN: None
Source Type: Journal
DOI: 10.1016/S0167-7799(01)01811-X Document Type: Review |
|
Times cited : (49)
|
|
References (19)
|
